Welcome!

News Feed Item

United States Interventional Cardiology Market Outlook to 2020

NEW YORK, Aug. 4, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Interventional Cardiology Market Outlook to 2020

http://www.reportlinker.com/p02133124/United-States-Interventional-Cardiology-Market-Outlook-to-2020.html

United States Interventional Cardiology Market Outlook to 2020

Summary

GlobalData's new report, "United States Interventional Cardiology Market Outlook to 2020", provides key market data on the United States Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Interventional Cardiology categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the United States Interventional Cardiology market.
- Key players covered include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc. and Cordis Corporation.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
2 Introduction 12
2.1 What Is This Report About? 12
2.2 Interventional Cardiology Market Segmentation 12
2.3 Definitions of Markets Covered in the Report 13
3 Interventional Cardiology Market, United States 16
3.1 Interventional Cardiology Market, United States, Revenue ($m), 2005-2012 16
3.2 Interventional Cardiology Market, United States, Revenue ($m), 2012-2020 18
3.2.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2005-2012 20
3.2.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2005-2012 22
3.2.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2005-2012 24
3.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2005-2012 26
3.2.5 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2005-2012 28
3.2.6 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2012-2020 30
3.2.7 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2012-2020 32
3.2.8 Coronary Stents Market, United States, Revenue ($m), by Segment, 2012-2020 34
3.2.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2012-2020 36
3.2.10 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2012-2020 38
3.3 Interventional Cardiology Market, United States, Volume (Units), 2005-2012 40
3.4 Interventional Cardiology Market, United States, Volume (Units), 2012-2020 42
3.4.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2005-2012 44
3.4.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2005-2012 46
3.4.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2005-2012 48
3.4.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2005-2012 50
3.4.5 PTCA Balloons Market, United States, Volume (Units), by Segment, 2005-2012 52
3.4.6 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2012-2020 54
3.4.7 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2012-2020 56
3.4.8 Coronary Stents Market, United States, Volume (Units), by Segment, 2012-2020 58
3.4.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2012-2020 60
3.4.10 PTCA Balloons Market, United States, Volume (Units), by Segment, 2012-2020 62
3.5 Interventional Cardiology Market, United States, Average Price ($), 2005-2020 64
3.6 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2011-2012 67
3.7 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2011-2012 68
4 Overview of Key Companies in United States, Interventional Cardiology Market 70
4.1 Boston Scientific Corporation 70
4.1.1 Company Overview 70
4.2 Abbott Laboratories 70
4.2.1 Company Overview 70
4.3 Medtronic, Inc. 71
4.3.1 Company Overview 71
4.4 Cordis Corporation 71
4.4.1 Company Overview 71
4.5 Terumo Corporation 71
4.5.1 Company Overview 71
4.6 Volcano Corporation 72
4.6.1 Company Overview 72
4.7 St. Jude Medical, Inc. 72
4.7.1 Company Overview 72
5 Interventional Cardiology Market Pipeline Products 73
6 Financial Deals Landscape 74
6.1 Acquisition 74
6.1.1 Cardinal Health Completes Acquisition Of AccessClosure For US$320 Million 74
6.1.2 Vanguard Acquires 6.7% Stake In Boston Scientific 76
6.1.3 Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 77
6.1.4 Maquet Cardiovascular Acquires LAAx, Developer Of Cardiovascular Surgery Device 78
6.1.5 Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 79
6.1.6 Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 81
6.2 Asset Transactions 83
6.2.1 Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US$3 Million 83
6.3 Debt Offerings 85
6.3.1 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 85
6.3.2 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 87
6.3.3 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 89
6.3.4 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 91
6.3.5 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 93
6.3.6 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 95
6.3.7 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 97
6.4 Merger 99
6.4.1 Emboline And VasoStitch Merge 99
6.5 Partnerships 100
6.5.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 100
6.5.2 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 101
6.5.3 Catheter Connections Enters Into Distribution Agreement With Merit Medical Systems For DualCap System 102
6.5.4 Philips Enters Into Distribution Agreement With Corindus For CorPath 200 System 103
6.6 Venture Financing 104
6.6.1 Cardiac Dimensions Raises US$20 Million In Venture Financing 104
6.6.2 Cardiac Dimensions Raises Us$0.38 Million In Venture Financing 105
6.6.3 Cardiac Dimensions Raises US$0.8 Million In Venture Financing 106
6.6.4 MC10 Raises US$20 Million In Venture Financing 107
6.6.5 Cardiac Dimensions Raises US$0.5 Million In Venture Financing 108
6.6.6 Apama Medical Raises US$3.2 Million In Series A-1 Financing Round 109
6.6.7 Cardiva Medical Raises US$3.4 Million In Venture Financing 110
6.6.8 Cardiac Dimensions Raises US$2.4 Million In Venture Financing 111
6.6.9 Cibiem Raises US$10 Million In Series A Financing 113
6.6.10 Cardiac Dimensions Raises US$6 Million In Venture Financing 115
7 Recent Developments 116
7.1 Corporate Communications 116
7.1.1 May 06, 2014: Hansen Medical Appoints Cary Vance as President and CEO 116
7.1.2 Apr 29, 2014: AngioDynamics Names Howard W. Donnelly Chairman of the Board of Directors 116
7.1.3 Mar 18, 2014: Theragenics Appoints Mark Kesti as Vice President of Sales for Galt Medical and NeedleTech Products 117
7.1.4 Mar 03, 2014: Boston Scientific Elects Edward J. Ludwig To Its Board Of Directors 117
7.1.5 Feb 18, 2014: SurModics Announces Changes to Board of Directors 118
7.1.6 Feb 10, 2014: Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company 118
7.1.7 Feb 10, 2014: Hansen Medical Appoints Chris Lowe as Interim CEO 119
7.1.8 Jan 20, 2014: Cardiva Medical Announces Appointment of Randy Hubbell, Chief Commercial Officer 119
7.1.9 Jan 07, 2014: Simbionix Welcomes New Latin and Central American Sales Manager 120
7.1.10 Jan 06, 2014: Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology 120
7.1.11 Dec 16, 2013: Boston Scientific Elects David Roux To Its Board of Directors 121
7.1.12 Dec 11, 2013: AngioDynamics Appoints John Soto Chief Commercial Officer 121
7.1.13 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 122
7.1.14 Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President 124
7.1.15 Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical's Peripheral Intervention Clinical Division 124
7.1.16 Nov 21, 2013: Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific 125
7.1.17 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 125
7.1.18 Oct 24, 2013: Boston Scientific Announces Transition Plan For New Chief Financial Officer 126
7.1.19 Oct 22, 2013: Boston Scientific Eliminates 1500 Jobs 126
7.1.20 Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group 127
7.1.21 Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio & Vascular Business and the Appointment of Richard Johnson as Interim CFO 127
7.1.22 Sep 20, 2013: SurModics Announces Board Changes 128
7.1.23 Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic Intervention Clinical Division 128
7.1.24 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 129
7.1.25 Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation 130
7.1.26 Jul 17, 2013: Marjorie Bowen Appointed to Hansen Medical's Board of Directors 130
7.2 Financial Announcements 131
7.2.1 May 07, 2014: Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results 131
7.2.2 May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 132
7.2.3 Apr 29, 2014: Boston Scientific Announces Results For First Quarter Ended March 31, 2014 134
7.2.4 Apr 09, 2014: AngioDynamics Reports Fiscal 2014 Third Quarter Financial Results 135
7.2.5 Feb 20, 2014: Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results 137
7.2.6 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 139
7.2.7 Feb 04, 2014: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2012 140
7.2.8 Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results 143
7.2.9 Jan 13, 2014: Hansen Medical Reports Preliminary Fourth Quarter and Full-Year 2013 Results and Recent Business Highlights 144
7.2.10 Jan 09, 2014: AngioDynamics Reports Fiscal 2014 Second Quarter Financial Results 145
7.2.11 Dec 12, 2013: AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results 147
7.2.12 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 147
7.2.13 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 149
7.2.14 Nov 07, 2013: Accellent Announces Third Quarter 2013 Results 149
7.2.15 Nov 06, 2013: Hansen Medical Reports Third Quarter and Nine-Month 2013 Results 150
7.2.16 Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results 152
7.2.17 Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5 154
7.2.18 Oct 28, 2013: Hansen Medical Announces Third Quarter 2013 Results Conference Call 154
7.2.19 Oct 24, 2013: Boston Scientific Announces Results For Third Quarter Ended September 30, 2013 155
7.2.20 Oct 10, 2013: Boston Scientific To Webcast Conference Call Discussing Third Quarter 2013 Financial Results On October 24 156
7.2.21 Oct 10, 2013: AngioDynamics Reports Fiscal 2014 First Quarter Financial Results 156
7.2.22 Sep 19, 2013: AngioDynamics to Report Fiscal 2014 First Quarter Financial Results 158
7.2.23 Aug 20, 2013: Medtronic Reports First Quarter Earnings 159
7.2.24 Aug 13, 2013: Accellent Announces Second Quarter 2013 Results 160
7.2.25 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 161
7.2.26 Aug 08, 2013: Theragenics Corporation Reports Second Quarter 2013 Results 162
7.2.27 Aug 07, 2013: Hansen Medical Reports Second Quarter and Six-Month 2013 Results 163
7.2.28 Aug 06, 2013: Accellent Announces Timing of Second Quarter 2013 Earnings Release and Conference Call 166
7.2.29 Aug 06, 2013: Theragenics to Report Second Quarter 2013 Financial Results on August 8, 2013 166
7.2.30 Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results 166
7.2.31 Jul 25, 2013: Boston Scientific Announces Results For Second Quarter Ended June 30, 2013 168
7.2.32 Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31 169
7.2.33 Jul 23, 2013: Hansen Medical Reports Preliminary Second Quarter 2013 Results 170
7.2.34 Jul 11, 2013: AngioDynamics Reports Fiscal 2013 Fourth Quarter Financial Results 171
7.2.35 Jul 11, 2013: Boston Scientific To Webcast Conference Call Discussing Second Quarter 2013 Financial Results On July 25 172
7.2.36 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 173
7.3 Government and Public Interest 175
7.3.1 Mar 11, 2014: Simbionix Provides Comprehensive Virtual Reality Training for the Fast Arthroscopy Curriculum 175
7.3.2 Jan 08, 2014: Hansen Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference 175
7.3.3 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 175
7.3.4 Jan 02, 2014: Boston Scientific To Participate In 32nd Annual J.P. Morgan Healthcare Conference 176
7.3.5 Jan 02, 2014: Boston Scientific To Participate In 32nd Annual J.P. Morgan Healthcare Conference 176
7.3.6 Dec 18, 2013: AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference 176
7.3.7 Dec 10, 2013: Collaboration Between Simbionix And 1st MSMU To Integrate A Russian Developed Assessment System To Enhance Laparoscopic Training 177
7.3.8 Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference 177
7.3.9 Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference 177
7.3.10 Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference 178
7.3.11 Nov 26, 2013: Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference 178
7.3.12 Nov 25, 2013: Hansen Medical to Present at 25th Annual Piper Jaffray Healthcare Conference 178
7.3.13 Nov 22, 2013: Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference 178
7.3.14 Nov 20, 2013: AngioDynamics to Present at 25th Annual Piper Jaffray Healthcare Conference 178
7.3.15 Nov 12, 2013: SurModics to Present at Canaccord Genuity Medical Technology & Diagnostics Conference 179
7.3.16 Nov 11, 2013: Hansen Medical to Present at Barclays Select Series 2013: Select Growth Conference 179
7.3.17 Nov 04, 2013: AngioDynamics to Present at Upcoming Investor Conferences 179
7.3.18 Oct 31, 2013: Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference 179
7.3.19 Sep 06, 2013: Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference 180
7.3.20 Sep 04, 2013: Boston Scientific To Participate In 2013 Stifel Nicolaus Healthcare Conference 180
7.3.21 Aug 28, 2013: AngioDynamics to Present at the Stifel Nicolaus 2013 Healthcare Conference 180
7.3.22 Aug 27, 2013: SurModics to Present at CL King's Best Ideas Conference 180
7.3.23 Aug 01, 2013: AngioDynamics to Present at 33rd Annual Canaccord Growth Conference 180
7.3.24 May 21, 2013: SurModics to Present at the Jefferies Global Healthcare Conference 181
7.4 Legal And Regulatory 181
7.4.1 Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve 181
7.4.2 Mar 20, 2014: AngioDynamics Awarded $74.9 Million in Case Against biolitec 181
7.4.3 Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test 182
7.4.4 Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures 182
7.4.5 Dec 11, 2013: Federal Court Shuts Down Janzen Patent Infringement Claim Against AccessClosure 183
7.4.6 Oct 19, 2013: Medtronic Statement on Medical Device Security 183
7.4.7 Sep 17, 2013: OrbusNeich, Boston Scientific Settle Patent Litigation 184
7.4.8 Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records 184
7.4.9 Jul 01, 2013: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc. 184
7.5 Other Significant Developments 185
7.5.1 Mar 19, 2014: Boston Scientific Receives Prestigious Shingo Award for Operational Excellence 185
7.5.2 Feb 24, 2014: Cesca Therapeutics and Cook Medical Enter Supply Agreement for a Phase 1b Clinical Trial 185
7.5.3 Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014 186
7.5.4 Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai 186
7.5.5 Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles 187
7.5.6 Nov 12, 2013: Teleflex Awarded New Agreement by Novation for Arrow Intra-Aortic Balloon Catheters and Pumps 188
7.5.7 Oct 10, 2013: AngioDynamics Signs Multi-Year, Sole-Source Agreement With Large Integrated Delivery Network Group 189
7.5.8 Sep 10, 2013: The Abraaj Group Invests In Steripharma 189
7.5.9 Sep 03, 2013: SurModics Announces Organizational Changes 190
7.5.10 Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014 191
7.5.11 Jul 22, 2013: SurModics to Present at the InvestMNt Conference 191
7.5.12 Jul 10, 2013: Hansen Medical to Replace Current Debt Facility With New $33 Million, Interest-Only Debt Facility Through 2017 191
7.6 Product News 192
7.6.1 May 10, 2014: Study Of Boston Scientific Latitude™ Remote Patient Management System Presented At Heart Rhythm 2014 Demonstrates Significant Reduction In Mortality And Hospitalization 192
7.6.2 May 10, 2014: Late-Breaking Clinical Trial Results Show Medtronic-Exclusive Pacemaker Algorithm Significantly Delays Atrial Fibrillation 193
7.6.3 May 09, 2014: Datascope Corp/MAQUET Issues Worldwide Voluntary Recall of the System 98/98XT, CS100, CS100i and CS300 Intra-Aortic Balloon Pumps For Potential Mechanical Failure of the Power Supply Fan Assembly 194
7.6.4 Apr 24, 2014: Premier Biomedical Receives Notice of Allowance on Broad Base Patent 194
7.6.5 Mar 30, 2014: New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained Lower Mortality Rates After Receiving Boston Scientific CRT Defibrillators 195
7.6.6 Mar 29, 2014: AccessClosure Launches the Next-Generation Mynx Ace Vascular Closure Device at Annual ACC Meeting 196
7.6.7 Mar 27, 2014: Spectranetics Announces Early Success of EXCITE ISR; Clinical Trial Demonstrated Safety and Efficacy Superiority 196
7.6.8 Feb 24, 2014: Spectranetics Achieves Statistical Endpoints of EXCITE ISR Adjunct Analysis 197
7.6.9 Nov 18, 2013: Simbionix New ANGIO Mentor Suite Promotes Endovascular Team Training in a True-to-Life Clinical Environment 198
7.6.10 Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall 199
7.6.11 Nov 14, 2013: Endovascular Aneurysm Training Module Now Supports Vascutek's Anaconda Devices 199
7.6.12 Sep 11, 2013: Fanisi Capital Acquires Stake In Haltons For US$3 Million 200
7.6.13 Aug 28, 2013: Coqui Radio Pharma Raises US$1 Million In Venture Financing 201
7.6.14 May 30, 2013: Cardiovascular Systems Enrolls First Patient In Liberty 360° Study 201
7.7 Research And Development 202
7.7.1 May 30, 2013: Cook Medical Joins With Indiana Life Science Businesses, Academia And Government To Help Launch Bioscience Research Center 202
7.8 Strategy And Business Planning 203
7.8.1 Feb 04, 2014: Purdue Research Foundation, Cook Medical partner on $12 million project to support life sciences startup opportunities 203
7.8.2 Dec 05, 2013: AngioDynamics Announces Operational Excellence Program 204
7.8.3 Nov 14, 2013: Cook Medical Opens New Innovation Centre in Limerick, Ireland 204
7.8.4 Sep 17, 2013: Boston Scientific Opens Institute For Advancing Science, Innovation Center In Shanghai 205
7.8.5 Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland 206
7.8.6 Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies 206
7.8.7 Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation 208
8 Appendix 209
8.1 Research Methodology 210
8.1.1 Coverage 210
8.1.2 Secondary Research 210
8.1.3 Primary Research 211
8.1.4 Market Modeling and Forecasting 212
8.1.5 Company Share Analysis 215
8.1.6 Distribution Share Analysis 216
8.2 Expert Panel 216
8.3 GlobalData Consulting 217
8.4 Contact Us 217
8.5 Disclaimer 217


1.1
List of Tables


Table 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 19
Table 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 21
Table 4: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 23
Table 5: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 25
Table 6: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 27
Table 7: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 29
Table 8: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 31
Table 9: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 33
Table 10: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 35
Table 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 37
Table 12: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 39
Table 13: Interventional Cardiology Market, United States, Volume (Units), Historic, 2005-2012 41
Table 14: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2012-2020 43
Table 15: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2005-2012 45
Table 16: Cardiac Catheters Market, United States, Volume (Units), Historic, 2005-2012 47
Table 17: Coronary Stents Market, United States, Volume (Units), Historic, 2005-2012 49
Table 18: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2005-2012 51
Table 19: PTCA Balloons Market, United States, Volume (Units), Historic, 2005-2012 53
Table 20: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2012-2020 55
Table 21: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2012-2020 57
Table 22: Coronary Stents Market, United States, Volume (Units), Forecast, 2012-2020 59
Table 23: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2012-2020 61
Table 24: PTCA Balloons Market, United States, Volume (Units), Forecast, 2012-2020 63
Table 25: Interventional Cardiology Market, United States, Average Price ($), Historic, 2005-2012 64
Table 26: Interventional Cardiology Market, United States, Average Price ($), Forecast, 2012-2020 65
Table 27: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 67
Table 28: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 69
Table 29: Interventional Cardiology Market Pipeline Products 73
Table 30: Cardinal Health Completes Acquisition Of AccessClosure For US$320 Million 74
Table 31: Vanguard Acquires 6.7% Stake In Boston Scientific 76
Table 32: Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 77
Table 33: Maquet Cardiovascular Acquires LAAx, Developer Of Cardiovascular Surgery Device 78
Table 34: Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 79
Table 35: Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 81
Table 36: Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US$3 Million 83
Table 37: Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 85
Table 38: Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 87
Table 39: Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 89
Table 40: Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 91
Table 41: Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 93
Table 42: Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 95
Table 43: Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 97
Table 44: Emboline And VasoStitch Merge 99
Table 45: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 100
Table 46: Coherex Medical Enters Into Distribution Agreement With Biosense Webster 101
Table 47: Catheter Connections Enters Into Distribution Agreement With Merit Medical Systems For DualCap System 102
Table 48: Philips Enters Into Distribution Agreement With Corindus For CorPath 200 System 103
Table 49: Cardiac Dimensions Raises US$20 Million In Venture Financing 104
Table 50: Cardiac Dimensions Raises Us$0.38 Million In Venture Financing 105
Table 51: Cardiac Dimensions Raises US$0.8 Million In Venture Financing 106
Table 52: MC10 Raises US$20 Million In Venture Financing 107
Table 53: Cardiac Dimensions Raises US$0.5 Million In Venture Financing 108
Table 54: Apama Medical Raises US$3.2 Million In Series A-1 Financing Round 109
Table 55: Cardiva Medical Raises US$3.4 Million In Venture Financing 110
Table 56: Cardiac Dimensions Raises US$2.4 Million In Venture Financing 111
Table 57: Cibiem Raises US$10 Million In Series A Financing 113
Table 58: Cardiac Dimensions Raises US$6 Million In Venture Financing 115
Table 59: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 212


1.2
List of Figures


Figure 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 18
Figure 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 20
Figure 4: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 22
Figure 5: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 24
Figure 6: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 26
Figure 7: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 28
Figure 8: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 30
Figure 9: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 32
Figure 10: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 34
Figure 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 36
Figure 12: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 38
Figure 13: Interventional Cardiology Market, United States, Volume (Units), Historic, 2005-2012 40
Figure 14: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2012-2020 42
Figure 15: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2005-2012 44
Figure 16: Cardiac Catheters Market, United States, Volume (Units), Historic, 2005-2012 46
Figure 17: Coronary Stents Market, United States, Volume (Units), Historic, 2005-2012 48
Figure 18: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2005-2012 50
Figure 19: PTCA Balloons Market, United States, Volume (Units), Historic, 2005-2012 52
Figure 20: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2012-2020 54
Figure 21: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2012-2020 56
Figure 22: Coronary Stents Market, United States, Volume (Units), Forecast, 2012-2020 58
Figure 23: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2012-2020 60
Figure 24: PTCA Balloons Market, United States, Volume (Units), Forecast, 2012-2020 62
Figure 25: Interventional Cardiology Market, United States, Company Share (%), 2012 68
Figure 26: GlobalData Epidemiology-Based Forecasting Model 214
Figure 27: GlobalData Capital Equipment-Based Forecasting Model 215
Figure 28: Primary Interviews by Participant Type (%) 216


To order this report: United States Interventional Cardiology Market Outlook to 2020
http://www.reportlinker.com/p02133124/United-States-Interventional-Cardiology-Market-Outlook-to-2020.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Column Technologies will exhibit at SYS-CON's @DevOpsSummit at Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Established in 1998, Column Technologies is a global technology solutions provider with over 400 employees, headquartered in the United States with offices in Canada, India, and the United Kingdom. Column Technologies provides “Best of Breed” technology solutions that automate the key DevOps principal...
More and more companies are looking to microservices as an architectural pattern for breaking apart applications into more manageable pieces so that agile teams can deliver new features quicker and more effectively. What this pattern has done more than anything to date is spark organizational transformations, setting the foundation for future application development. In practice, however, there are a number of considerations to make that go beyond simply “build, ship, and run,” which changes ho...
SYS-CON Events announced today that AppNeta, the leader in performance insight for business-critical web applications, will exhibit and present at SYS-CON's @DevOpsSummit at Cloud Expo New York, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. AppNeta is the only application performance monitoring (APM) company to provide solutions for all applications – applications you develop internally, business-critical SaaS applications you use and the networks that deli...
Fortunately, meaningful and tangible business cases for IoT are plentiful in a broad array of industries and vertical markets. These range from simple warranty cost reduction for capital intensive assets, to minimizing downtime for vital business tools, to creating feedback loops improving product design, to improving and enhancing enterprise customer experiences. All of these business cases, which will be briefly explored in this session, hinge on cost effectively extracting relevant data from ...
When building large, cloud-based applications that operate at a high scale, it’s important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. “Fly two mistakes high” is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Lee...
SYS-CON Events announced today that (ISC)²® (“ISC-squared”) will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Two leading non-profits focused on cloud and information security, (ISC)² and Cloud Security Alliance (CSA), developed the Certified Cloud Security Professional (CCSP) certification to address the increased demand for cloud security expertise due to rapid growth in cloud. Recently named “The Next...
SYS-CON Events announced today that iDevices®, the preeminent brand in the connected home industry, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. iDevices, the preeminent brand in the connected home industry, has a growing line of HomeKit-enabled products available at the largest retailers worldwide. Through the “Designed with iDevices” co-development program and its custom-built IoT Cloud Infrastruc...
The Art of DevOps provides a fun overview to help teams understand DevOps. Written in the style of the famous 6th century Chinese manuscript “The Art of War,” this eBook describes DevOps in the form of a mission to continuously deliver assets to the operational battlegrounds safely, securely, and quickly. It’s a fun read with valuable insights.
There will be new vendors providing applications, middleware, and connected devices to support the thriving IoT ecosystem. This essentially means that electronic device manufacturers will also be in the software business. Many will be new to building embedded software or robust software. This creates an increased importance on software quality, particularly within the Industrial Internet of Things where business-critical applications are becoming dependent on products controlled by software. Qua...
As enterprises work to take advantage of Big Data technologies, they frequently become distracted by product-level decisions. In most new Big Data builds this approach is completely counter-productive: it presupposes tools that may not be a fit for development teams, forces IT to take on the burden of evaluating and maintaining unfamiliar technology, and represents a major up-front expense. In his session at @BigDataExpo at @ThingsExpo, Andrew Warfield, CTO and Co-Founder of Coho Data, will dis...
The Quantified Economy represents the total global addressable market (TAM) for IoT that, according to a recent IDC report, will grow to an unprecedented $1.3 trillion by 2019. With this the third wave of the Internet-global proliferation of connected devices, appliances and sensors is poised to take off in 2016. In his session at @ThingsExpo, David McLauchlan, CEO and co-founder of Buddy Platform, will discuss how the ability to access and analyze the massive volume of streaming data from mil...
WebSocket is effectively a persistent and fat pipe that is compatible with a standard web infrastructure; a "TCP for the Web." If you think of WebSocket in this light, there are other more hugely interesting applications of WebSocket than just simply sending data to a browser. In his session at 18th Cloud Expo, Frank Greco, Director of Technology for Kaazing Corporation, will compare other modern web connectivity methods such as HTTP/2, HTTP Streaming, Server-Sent Events and new W3C event APIs ...
The cloud competition for database hosts is fierce. How do you evaluate a cloud provider for your database platform? In his session at 18th Cloud Expo, Chris Presley, a Solutions Architect at Pythian, will give users a checklist of considerations when choosing a provider. Chris Presley is a Solutions Architect at Pythian. He loves order – making him a premier Microsoft SQL Server expert. Not only has he programmed and administered SQL Server, but he has also shared his expertise and passion w...
Advances in technology and ubiquitous connectivity have made the utilization of a dispersed workforce more common. Whether that remote team is located across the street or country, management styles/ approaches will have to be adjusted to accommodate this new dynamic. In his session at 17th Cloud Expo, Sagi Brody, Chief Technology Officer at Webair Internet Development Inc., focused on the challenges of managing remote teams, providing real-world examples that demonstrate what works and what do...
SYS-CON Events announced today that Men & Mice, the leading global provider of DNS, DHCP and IP address management overlay solutions, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. The Men & Mice Suite overlay solution is already known for its powerful application in heterogeneous operating environments, enabling enterprises to scale without fuss. Building on a solid range of diverse platform support,...